TY - JOUR
T1 - Clinical outcomes of Clutch Cutter endoscopic submucosal dissection for older patients with early gastric cancer
AU - Otsuka, Yoshihiro
AU - Akahoshi, Kazuya
AU - Yasunaga, Kayoko
AU - Kubokawa, Masaru
AU - Gibo, Junya
AU - Osada, Shigeki
AU - Tokumaru, Kayo
AU - Miyamoto, Kazuaki
AU - Sato, Takao
AU - Shiratsuchi, Yuki
AU - Oya, Masafumi
AU - Koga, Hidenobu
AU - Ihara, Eikichi
AU - Nakamura, Kazuhiko
N1 - Publisher Copyright:
© The Author(s) 2017.
PY - 2017/10/1
Y1 - 2017/10/1
N2 - AIM To evaluate the clinical outcome of endoscopic subSubmitmucosal dissection using the Clutch Cutter (ESDCC) in older patients. METHODS We reviewed 232 consecutive patients with early gastric cancer who underwent ESDCC between June 2010 and February 2014 at Aso Iizuka Hospital. We divided patients into two groups according to age: Older patients ( > 80 years, n = 64) and non-older patients (= 80 years, n = 168). We retrospectively compared the prevalence rates of pre-existing comorbidities, anticoagulant therapy, en bloc resection, mean duration of hospitalization, incidence of ESDCC-related complications, change in performance status (PS) before and after ESDCC, and financial cost of admission. RESULTS The older group comprised 64 patients with a mean age of 84.1 years, and the non-older group comprised 168 patients with a mean age of 69.5 years. Older patients had significantly more pre-existing comorbidities than did non-older patients, specifically heart disease (P < 0.05). The en bloc resection rate in non-older patients was significantly higher than that in older patients (100% vs 95.3%, P = 0.02). There were no significant differences between the older and non-older groups in the incidence of ESDCC-related complications (i.e., postoperative bleeding and perforation) and the post-ESDCC change in PS. There were also no significant differences between the older and non-older groups in the mean duration of hospitalization (11.4 and 10.7 d, respectively) and financial cost of admission (657040 JPY and 574890 JPY, respectively). CONCLUSION ESDCC has a good clinical outcome in older patients.
AB - AIM To evaluate the clinical outcome of endoscopic subSubmitmucosal dissection using the Clutch Cutter (ESDCC) in older patients. METHODS We reviewed 232 consecutive patients with early gastric cancer who underwent ESDCC between June 2010 and February 2014 at Aso Iizuka Hospital. We divided patients into two groups according to age: Older patients ( > 80 years, n = 64) and non-older patients (= 80 years, n = 168). We retrospectively compared the prevalence rates of pre-existing comorbidities, anticoagulant therapy, en bloc resection, mean duration of hospitalization, incidence of ESDCC-related complications, change in performance status (PS) before and after ESDCC, and financial cost of admission. RESULTS The older group comprised 64 patients with a mean age of 84.1 years, and the non-older group comprised 168 patients with a mean age of 69.5 years. Older patients had significantly more pre-existing comorbidities than did non-older patients, specifically heart disease (P < 0.05). The en bloc resection rate in non-older patients was significantly higher than that in older patients (100% vs 95.3%, P = 0.02). There were no significant differences between the older and non-older groups in the incidence of ESDCC-related complications (i.e., postoperative bleeding and perforation) and the post-ESDCC change in PS. There were also no significant differences between the older and non-older groups in the mean duration of hospitalization (11.4 and 10.7 d, respectively) and financial cost of admission (657040 JPY and 574890 JPY, respectively). CONCLUSION ESDCC has a good clinical outcome in older patients.
UR - http://www.scopus.com/inward/record.url?scp=85041750536&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041750536&partnerID=8YFLogxK
U2 - 10.4251/wjgo.v9.i10.416
DO - 10.4251/wjgo.v9.i10.416
M3 - Article
AN - SCOPUS:85041750536
SN - 1948-5204
VL - 9
SP - 416
EP - 422
JO - World Journal of Gastrointestinal Oncology
JF - World Journal of Gastrointestinal Oncology
IS - 10
ER -